6.22
-0.23 (-3.57%)
| Penutupan Terdahulu | 6.45 |
| Buka | 6.39 |
| Jumlah Dagangan | 125,867 |
| Purata Dagangan (3B) | 121,873 |
| Modal Pasaran | 152,326,544 |
| Harga / Jualan (P/S) | 35.78 |
| Harga / Buku (P/B) | 17.03 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 2 Aug 2023 - 7 Aug 2023 |
| Margin Keuntungan | -264.71% |
| Margin Operasi (TTM) | -1,289.41% |
| EPS Cair (TTM) | -0.480 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -35.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 37.06% |
| Nisbah Semasa (MRQ) | 1.23 |
| Aliran Tunai Operasi (OCF TTM) | -15.86 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -7.19 M |
| Pulangan Atas Aset (ROA TTM) | -41.39% |
| Pulangan Atas Ekuiti (ROE TTM) | -217.95% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Menaik |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Menaik | |
| Stok | DURECT Corporation | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -5.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 0.0 |
| Purata | -1.79 |
|
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe . |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 11.82% |
| % Dimiliki oleh Institusi | 22.32% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |